Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
niostem is a German health-technology company that has developed a non-invasive wearable device designed to reverse hair loss and stimulate hair regrowth. The company's core technology utilizes low-level bioelectrical stimulation to reactivate dormant hair follicle stem cells, specifically targeting androgenetic alopecia. Unlike traditional pharmacological treatments, niostem's solution is drug-free and focuses on the regenerative potential of the body's own stem cells. The device is integrated with a mobile application to track progress and ensure consistent usage. niostem successfully transitioned from research at the Max Planck Institute to a commercial product available to consumers worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on niostem.